Conversely, in the Osi group, the prognostic role of VEGFR2 and VEGF‐C expression was slightly different based on EGFR mutation status; therefore, information regarding the protein expression of VEGF within tumor cells may be useful to suppress resistance to osimertinib for the choice of add‐on VEGF inhibitors. Here, VEGFA is linked to neoplasm.